VERICEL CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.05 USD | +1.32% |
|
+5.28% | +29.32% |
| Apr. 19 | Vericel Insider Sold Shares Worth $1,593,550, According to a Recent SEC Filing | MT |
| Mar. 15 | Vericel Insider Sold Shares Worth $1,552,075, According to a Recent SEC Filing | MT |
Chart calendar Vericel Corporation
10d368fbe058fc5ff5b30f9d9.OLeM1s7Hb-KeibtMNUavslywpZ79RpZLoo88WtG2wvI.XNjevKL0B66m4d0AVHD58RHJ082QN8Qc1tB9H4iGkbFaxeOYl_Qciqywiw~0d2d8a81d9bcc61831e29928bfeee10f
Upcoming events on Vericel Corporation
Past events on Vericel Corporation
| 2024-03-05 11:10 am | TD Cowen Health Care Conference |
| 2024-02-29 08:30 am | Q4 2023 Earnings Call |
| 2024-02-29 07:55 am | Q4 2023 Earnings Release |
| 2024-02-12 11:00 am | Canaccord Genuity Musculoskeletal Conference |
| 2024-01-10 10:30 am | JPMorgan Healthcare Conference |
| 2023-11-15 10:00 am | Stephens Investment Conference |
| 2023-11-08 08:30 am | Q3 2023 Earnings Call |
| 2023-11-08 07:55 am | Q3 2023 Earnings Release |
| 2023-09-12 07:30 am | Morgan Stanley Global Healthcare Conference |
| 2023-08-02 08:30 am | Q2 2023 Earnings Call |
| 2023-08-02 07:55 am | Q2 2023 Earnings Release |
| 2023-05-10 08:30 am | Q1 2023 Earnings Call |
| 2023-05-10 07:55 am | Q1 2023 Earnings Release |
| 2023-05-03 09:00 am | Annual General Meeting |
| 2023-03-07 12:30 pm | Canaccord Genuity Musculoskeletal Conference |
| 2023-02-23 08:30 am | FY 2022 Earnings Call |
| 2023-02-23 07:55 am | FY 2022 Earnings Release |
| 2023-01-11 10:30 am | JP Morgan Healthcare Conference |
| 2022-11-17 11:00 am | Stephens Investment Conference |
| 2022-11-17 10:00 am | Canaccord Genuity CG MedTech, Diagnostics and Digital Health & Services Forum |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 118 117 0.35% | 124 124 0.17% | 156 157 -0.32% | 164 165 -0.16% | 198 197 0.01% | 239 |
|
EBITDA Million USD | Released Forecast Spread | -9,51 -10,5 9.46% | 18,6 16,7 10.99% | 29,5 32,0 -7.86% | 24,2 22,6 6.9% | 33,9 30,7 10.29% | 48,5 |
|
EBIT Million USD | Released Forecast Spread | -11,3 -11,5 2.23% | 2,37 0,04 6354.42% | -7,85 -5,61 -39.94% | -17,1 -21,4 20.3% | -6,46 -10,2 36.88% | 5,36 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,67 -10,3 5.89% | 3,04 1,05 190.64% | -7,58 -4,23 -79.37% | -16,0 -20,8 23.27% | -2,37 -7,32 67.65% | 6,72 |
|
Net income Million USD | Released Forecast Spread | -9,67 -10,4 6.9% | 2,86 0,49 479.46% | -7,47 -5,39 -38.6% | -16,7 -20,9 20.12% | -3,18 -7,63 58.28% | 4,27 |
|
EPS USD | Released Forecast Spread | -0,22 -0,23 5.04% | 0,06 0,01 700% | -0,16 -0,12 -37.93% | -0,35 -0,44 21.17% | -0,07 -0,16 56.25% | 0,08 |
| Announcement Date | 25/02/20 | 24/02/21 | 24/02/22 | 23/02/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 47,6 48,1 -1.03% | 36,1 34,3 5.16% | 37,0 38,3 -3.39% | 38,6 39,9 -3.38% | 52,7 53,0 -0.5% | 41,0 37,4 9.76% | 45,9 42,1 9% | 45,6 45,1 0.96% | 65,0 65,0 0.03% | 49,1 | 54,3 | 57,0 | 78,8 | 60,3 |
|
EBITDA Million USD | Released Forecast Spread | 12,8 15,3 -16.54% | 3,24 4,14 -21.71% | 2,77 5,20 -46.7% | 3,33 6,08 -45.32% | 14,9 13,4 10.85% | 1,70 4,72 -63.96% | 4,44 2,52 76.11% | 5,44 4,31 26.25% | 22,3 19,1 16.56% | 4,74 | 7,17 | 8,49 | 28,1 | 11,2 |
|
EBIT Million USD | Released Forecast Spread | 4,14 6,39 -35.15% | -7,27 -4,55 -59.84% | -9,08 -5,95 -52.59% | -6,79 -4,91 -38.37% | 6,09 1,74 249.15% | -8,18 -7,51 -8.87% | -5,96 -7,36 19.04% | -5,06 -6,15 17.71% | 12,7 9,00 41.42% | -5,49 | -2,68 | -1,49 | 15,0 | -0,25 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 4,21 7,57 -44.38% | -7,09 -4,21 -68.31% | -8,96 -5,87 -52.76% | -6,56 -4,73 -38.69% | 6,62 1,77 274% | -7,50 -7,41 -1.09% | -5,02 -7,75 35.2% | -3,95 -5,99 34.12% | 14,1 9,20 53.25% | -5,17 | -2,33 | -1,14 | 15,4 | 0,09 |
|
Net income Million USD | Released Forecast Spread | 4,54 6,60 -31.24% | -7,09 -3,79 -86.99% | -8,96 -5,79 -54.89% | -6,58 -4,84 -35.96% | 5,92 1,72 244.18% | -7,50 -7,41 -1.09% | -5,02 -7,29 31.1% | -3,66 -5,75 36.38% | 13,0 8,59 51.3% | -5,33 | -2,65 | -1,07 | 13,3 | -0,08 |
|
EPS USD | Released Forecast Spread | 0,09 0,14 -34.78% | -0,15 -0,12 -28.57% | -0,19 -0,12 -55.74% | -0,14 -0,10 -37.25% | 0,13 0,04 261.11% | -0,16 -0,15 -4.35% | -0,11 -0,15 27.63% | -0,08 -0,12 34.25% | 0,26 0,17 54.76% | -0,11 | -0,06 | -0,02 | 0,26 | -0,03 |
| Announcement Date | 24/02/22 | 04/05/22 | 03/08/22 | 09/11/22 | 23/02/23 | 10/05/23 | 02/08/23 | 08/11/23 | 29/02/24 | - | - | - | - | - |
More events
Past sector events for Vericel Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VCEL Stock
- Calendar Vericel Corporation
